Gulf & Middle East · News · Gulf Daily News
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen
Chinese biotech company Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Novartis to develop messenger RNA-based therapies, underscoring the…
Read the full article on Gulf Daily News Sign in to saveMediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.gdnonline.com)



